Works by Lee, Keun Wook

Results: 194
    1
    2

    Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer.

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 620, doi. 10.1007/s10120-025-01604-y
    By:
    • Kim, Ji-Won;
    • Kyung, Dong Soo;
    • Ko, Won Yeong;
    • Kim, Hwang-Phill;
    • Hwang, Sung-Hyun;
    • Kim, Kui-Jin;
    • Lee, Ju Hyun;
    • Seo, Jeongmin;
    • Kang, Minsu;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Kim, Se Hyun;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Lee, Keun-Wook
    Publication type:
    Article
    3

    Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02274-z
    By:
    • Ruan, Dan-Yun;
    • Wu, Hao-Xiang;
    • Xu, Ye;
    • Munster, Pamela N.;
    • Deng, Yanhong;
    • Richardson, Gary;
    • Yan, Dong;
    • Lee, Myung-Ah;
    • Lee, Keun-Wook;
    • Pan, Hongming;
    • Hager, Steven;
    • Li, Xingya;
    • Wei, Shaozhong;
    • Hou, Xinfang;
    • Underhill, Craig;
    • Millward, Michael;
    • Nordman, Ina;
    • Zhang, Jingdong;
    • Shan, Jianzhen;
    • Han, Guohong
    Publication type:
    Article
    4
    5
    6
    7

    Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
    By:
    • Satake, Hironaga;
    • Lee, Keun-Wook;
    • Chung, Hyun Cheol;
    • Lee, Jeeyun;
    • Yamaguchi, Kensei;
    • Chen, Jen-Shi;
    • Yoshikawa, Takaki;
    • Amagai, Kenji;
    • Yeh, Kun-Huei;
    • Goto, Masahiro;
    • Chao, Yee;
    • Lam, Ka-On;
    • Han, Shi Rong;
    • Shiratori, Shinichi;
    • Shah, Sukrut;
    • Shitara, Kohei
    Publication type:
    Article
    8
    9
    10
    11
    12

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    13

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.

    Published in:
    Oncology (08909091), 2023, v. 37, n. 4, p. 175
    By:
    • Catenacci, Daniel V. T.;
    • Yoon-Koo Kang;
    • Uronis, Hope E.;
    • Keun-Wook Lee;
    • Ng, Matthew C. H.;
    • Enzinger, Peter C.;
    • Se Hoon Park;
    • Gold, Philip J.;
    • Lacy, Jill;
    • Hochster, Howard S.;
    • Sang Cheul Oh;
    • Yeul Hong Kim;
    • Marrone, Kristen A.;
    • Kelly, Ronan J.;
    • Juergens, Rosalyn A.;
    • Jong Gwang Kim;
    • Alcindor, Thierry;
    • Sun Jin Sym;
    • Eun-Kee Song;
    • Cheng Ean Chee
    Publication type:
    Article
    21

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    22
    23

    Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3359, doi. 10.1007/s00432-020-03316-5
    By:
    • Park, Ji Hyun;
    • Chun, Sang Hoon;
    • Lee, Yun-Gyoo;
    • Chang, Hyun;
    • Lee, Keun-Wook;
    • Kim, Hye Ryun;
    • Shin, Seong Hoon;
    • An, Ho Jung;
    • Lee, Kyoung Eun;
    • Hwang, In Gyu;
    • Ahn, Myung-Ju;
    • Kim, Sung-Bae;
    • Keam, Bhumsuk
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
    By:
    • Jung, Minkyu;
    • Ryu, Min-Hee;
    • Oh, Do Youn;
    • Kang, Myounghee;
    • Zang, Dae Young;
    • Hwang, In Gyu;
    • Lee, Keun-Wook;
    • Kim, Ki Hyang;
    • Shim, Byoung Yong;
    • Song, Eun Kee;
    • Sym, Sun Jin;
    • Han, Hye Sook;
    • Park, Young Lee;
    • Kim, Jin Soo;
    • Lee, Hyun Woo;
    • Lee, Moon Hee;
    • Koo, Dong-Hoe;
    • Song, Hong Suk;
    • Lee, Namsu;
    • Yang, Sung Hyun
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03197-9
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10642-7
    By:
    • Lam, Lyn Ley;
    • Pavlakis, Nick;
    • Shitara, Kohei;
    • Sjoquist, Katrin M.;
    • Martin, Andrew J.;
    • Yip, Sonia;
    • Kang, Yoon-Koo;
    • Bang, Yung-Jue;
    • Chen, Li-Tzong;
    • Moehler, Markus;
    • Bekaii-Saab, Tanios;
    • Alcindor, Thierry;
    • O'Callaghan, Christopher J.;
    • Tebbutt, Niall C.;
    • Hague, Wendy;
    • Chan, Howard;
    • Rha, Sun Young;
    • Lee, Keun-Wook;
    • Gebski, Val;
    • Jaworski, Anthony
    Publication type:
    Article